What is the recommended management for a child with a severe asthma episode who has partially responded to bronchodilator therapy?

In the management of a child experiencing a severe asthma episode who has only partially responded to bronchodilator therapy, the situation indicates a need for more aggressive treatment options. Intravenous aminophylline or salbutamol can be effective in this context. Aminophylline, which is a derivative of theophylline, acts as a bronchodilator and also has some anti-inflammatory properties; it can help improve lung function when conventional bronchodilator therapy (like nebulized salbutamol) does not suffice.

Utilizing intravenous delivery can ensure that the child receives a higher concentration of medication quickly, which is particularly important in acute and severe asthma exacerbations. This route may afford faster relief of symptoms compared to oral or inhaled medications in an acute setting.

While oral corticosteroids can be useful for addressing inflammation, they take time to exert their effects, making them less suitable for immediate management during a severe episode. Inhaled corticosteroids primarily serve as a long-term management strategy and are not intended for rapid intervention in acute exacerbations. Intravenous fluids might be necessary for hydration in cases of dehydration but do not directly address the bronchospasm or airway inflammation that occurs during an asthma attack.

Thus, intravenous aminophylline or salbutam